SpringWorks Therapeutics (SWTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist

36.350
+1.720+4.97%

Close Jan 21 16:00 ET

36.010
-0.340-0.94%

Pre 06:53 ET

2.70BMarket Cap-9.34P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TD Cowen Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $63
Moomoo NewsJan 16 07:33 ET · Ratings
TD Cowen Remains a Buy on Springworks Therapeutics (SWTX)
TipRanksJan 16 07:16 ET · Ratings
Barclays Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $63
Moomoo NewsJan 16 05:35 ET · Ratings
BofA Securities Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $55
Moomoo NewsJan 14 11:31 ET · Ratings
SWTX Announces 2024 Preliminary Results, 2025 Goals, Stock Down
Zacks Jan 14 11:05 ET
A Quick Look at Today's Ratings for SpringWorks Therapeutics(SWTX.US), With a Forecast Between $55 to $63
Moomoo NewsJan 14 08:00 ET · Ratings

Comments

Brianjh

Oct 17, 2024 09:21

Druckenmiller Stock Portfolio

Stanley Druckenmiller says he's ‘licking my wounds’ from selling Nvidia too soon
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...